- AMGN -5.00%
Amgen reports 45.9% decline in net income to $746m in Q2 2024
Yahoo Finance · 22 hours ago
Search results
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
- 312.50Add to watchlist-16.45 (-5.00%)At close:4:00 PM EDTWed. Aug 7, 2024312.01 -0.49 (-0.16%)Pre mkt:4:32 AM EDTThu. Aug 8, 2024Nasdaq Real Time Price (USD) · Pre-Market Time
- Open321.00High322.97Low306.63
- Mkt Cap167.92BP/E (TTM)53.79Div & Yield9.00 & 2.88%
- Prev. Close328.9552 Wk. Low248.3852 Wk. High346.85
What analysts are sayingTop storiesRelated stocks
Amgen ... Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total. [5]
Find the latest Amgen Inc. (AMGN) stock quote, history, news and other vital information to help you with your stock trading and investing.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products.
Live. Win. Thrive. We dare to ask questions that lead to lifesaving treatments. Join us in pushing the boundaries of biotechnology in a career at Amgen.
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We discover, develop, manufacture and deliver innovative medicines to help millions of patients.
Amgen is a pioneer in the science of using living cells to make biologic medicines. We helped invent the processes and tools that built the global biotech industry—turning it into a leading source of therapies for patients.
Amgen Worldwide. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world.
At Amgen we are committed to changing the course of cancer treatment for more than 40 years. Learn about all of the different Amgen Oncology web propoerties and resources that Amgen has to offer.
Amgen's powerful research and development group uses cutting-edge tools like AI, generative biology and human data to discover and develop new types of medicines to fight the world's toughest diseases. Many of Amgen's medicines are made through a highly complex process involving living cells.
